Asia-Pacific Dry Eye Products Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product [Antibiotic Drops, Hormone Drops, Artificial Tears (OTC Artificial Tears and Prescription Artificial Tears), and Others] and Type (Prescription Drug

Asia-Pacific Dry Eye Products Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product [Antibiotic Drops, Hormone Drops, Artificial Tears (OTC Artificial Tears and Prescription Artificial Tears), and Others] and Type (Prescription Drugs and OTC Drugs)

The APAC dry eye products market is expected to grow from US$ 1,298.49 million in 2021 to US$ 1,900.70 million by 2028. It is estimated to grow at a CAGR of 5.6% from 2021 to 2028.

Ongoing Research and Growing Pipeline for Dry Eye Products

The dry eye condition is expected to be seen in the majority of the population across the region in the coming years. Many research studies have proven dry eye as a lifestyle disease. Improvements or changes in daily habits such as sleep, diet, and exercise are included in the treatment of dry eyes. Additionally, the stressful life among people across the region is likely to increase the incidence of dry eyes, thereby propelling the demand for dry eye products in the coming years. Technological advancements have resulted in an increase in product development. Various companies are entering the market, which is contributing greatly to enhancing market growth. Various companies have designed innovative formulae to offer better eye drops for dry eye conditions. The cycle of product development is continuous and is likely to act as a vital growth factor during the forecast period. Some companies are focusing on innovating other forms of products that can treat dry eye conditions. Several innovations are likely to act as trending factors and are expected to contribute significantly to the market growth in the coming years across the region.

Market Overview

The APAC dry eye products market includes the consolidated markets for China, India, Japan, South Korea, Australia, and the Rest of APAC. Japan held the largest share of the APAC dry eye products market in 2021. In Japan, dry eye is the leading diagnosed eye condition that shows prevalent symptoms among high school students. The incidence among students is higher due to long hours in front of computers and mobiles. The incidence is seen widely among females wearing contact lenses. Therefore, the Japanese Dry Eye Society has introduced various diagnostic criteria for dry eye symptoms. In addition, technological development has allowed the Japanese to develop the P2Y2 antagonist Diquas and the mucin secretagogue Mucosta. The development of these products was based on the tear instability concept. The process of development was conducted for more than five years. At present, the products are widely prescribed. However, these eye drops have been commercially available since 2010 in Japan. Santen Pharmaceutical Co., Ltd has made its product Diquas, an ophthalmic solution, 3%, available since 2010. Similarly, in 2012, Otsuka Pharmaceutical Co., Ltd made its Mucosta ophthalmic suspension UD2% commercially available. Thus, the product development of eye drops for dry eye condition is likely to influence market growth.

APAC Dry Eye Products Market Revenue and Forecast to 2028 (US$ Million)

APAC Dry Eye Products Market Segmentation

The APAC dry eye products market is segmented based on product, type, and country.

Based on product, the APAC dry eye products market is segmented into artificial tears, antibiotic drops, hormone drops, and others. The artificial tears segment held the largest market share in 2021. The artificial tears segment is further bifurcated into OTC artificial tears and prescription artificial tears.

Based on type, the APAC dry eye products market is bifurcated into OTC drugs and prescription drugs. The OTC drugs segment held a larger market share in 2021.

Based on country, the APAC dry eye products market is segmented into China, India, Japan, South Korea, Australia, and the Rest of APAC. Japan dominated the market in 2021.

AbbVie Inc; Bausch Health Companies Inc.; Johnson and Johnson Services, Inc.; Novartis AG; OASIS Medical; OCuSOFT Inc.; Prestige Consumer Healthcare Inc.; ROHTO Pharmaceutical Co, Ltd.; Santen Pharmaceutical Co., Ltd.; and URSAPHARM Arzneimittel GmbH are among the leading companies operating in the APAC dry eye products market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe fiber reinforced polymer (FRP) rebars market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Europe fiber reinforced polymer (FRP) rebars market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.